MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 30.08.2022
Genetic Technologies Limited DPO 2011-2025 | GENE
DPO Jährlich Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 780 | 652 | 295 | 193 | 212 | 179 | 117 | 62.3 | 200 |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 780 | 62.3 | 299 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
139 | $ 101.5 | - | $ 18.8 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
125 | $ 16.66 | 5.75 % | $ 179 M |  China |
 |
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
104 | $ 1.57 | -3.4 % | $ 2 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
52 | $ 38.42 | -0.54 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
43.9 | $ 11.98 | 0.76 % | $ 340 M |  Israel |
 |
DexCom
DXCM
|
70.4 | $ 65.76 | -1.79 % | $ 25.4 B | USA |
 |
Danaher Corporation
DHR
|
66.4 | $ 226.02 | -0.21 % | $ 165 B | USA |
 |
Fulgent Genetics
FLGT
|
34.9 | $ 26.95 | -0.7 % | $ 815 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
44.2 | $ 19.75 | -3.94 % | $ 1.06 B | USA |
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
1.29 K | $ 3.37 | -5.86 % | $ 107 K | USA |
 |
Co-Diagnostics
CODX
|
106 | $ 0.31 | -9.72 % | $ 9.1 M | USA |
 |
IQVIA Holdings
IQV
|
126 | $ 222.26 | 0.02 % | $ 40.3 B | USA |
 |
Guardant Health
GH
|
83.6 | $ 103.49 | 1.39 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
56.3 | $ 134.29 | -0.43 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 196.54 | 1.84 % | $ 10.1 B | USA |
 |
Quotient Limited
QTNT
|
86.2 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
18.3 | $ 183.1 | 0.32 % | $ 20.3 B | USA |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 407.75 | 0.99 % | $ 29.9 B | Schweiz |
 |
Myriad Genetics
MYGN
|
42 | $ 6.97 | -3.33 % | $ 631 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 | $ 260.62 | -1.35 % | $ 21.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
6.52 | $ 182.8 | -2.03 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
27 | $ 699.0 | -0.74 % | $ 57.6 B | USA |
 |
NeoGenomics
NEO
|
20.7 | $ 12.06 | 1.73 % | $ 1.53 B | USA |
 |
Neogen Corporation
NEOG
|
62.7 | $ 6.79 | -1.09 % | $ 1.47 B | USA |
 |
Lantheus Holdings
LNTH
|
25.3 | $ 67.14 | 0.78 % | $ 4.65 B | USA |
 |
Agilent Technologies
A
|
50.1 | $ 140.44 | 0.56 % | $ 42.7 B | USA |
 |
Biomerica
BMRA
|
32.4 | $ 2.43 | -5.89 % | $ 5.58 M | USA |
 |
Bioventus
BVS
|
59.2 | $ 7.53 | -0.26 % | $ 472 M | USA |
 |
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | Israel |
 |
Pacific Biosciences of California
PACB
|
33.5 | $ 2.11 | -0.47 % | $ 535 M | USA |